
Intravenous Anaesthetic Agents are drugs administered directly into the bloodstream to induce rapid and controlled anaesthesia during surgical procedures or medical interventions. These agents act quickly to produce unconsciousness, sedation, or analgesia, making them essential in modern anaesthesia practice.
Commonly used intravenous anaesthetics include propofol, thiopental, etomidate, and ketamine, each with unique pharmacological properties, onset times, and durations of action. Understanding their mechanisms, clinical uses, and potential side effects is crucial for safe and effective anaesthesia management.
Intravenous anaesthetics are broadly categorized into two main groups based on their chemical structure and pharmacological properties: Opioids and Non-Opioids.
Opioids are primarily used for their potent analgesic (pain-relieving) properties. In the context of anaesthesia, they are often used as adjuncts during induction to blunt the sympathetic response to intubation.
Common Agents: Fentanyl, Sufentanil, Alfentanil, and Remifentanil.
Mechanism: They act on specific receptors ($\mu$, $\kappa$, and $\delta$) in the brain and spinal cord to inhibit pain transmission.
Non-Opioids are the primary agents used for the induction of unconsciousness.
Common Agents: Propofol, Etomidate, Ketamine, and Barbiturates (like Thiopental Sodium).
Mechanism: Most of these agents (except Ketamine) work by enhancing the inhibitory neurotransmitter GABA, leading to CNS depression.
Every intravenous anaesthetic agent exerts a unique influence on the body's vital systems. Selecting the right drug requires an understanding of how it affects the CNS, CVS, and Respiratory systems.
Most agents cause a decrease in cerebral metabolic rate and intracranial pressure (ICP).
Propofol & Barbiturates: Potent anticonvulsants that significantly reduce ICP.
Ketamine: Uniquely causes "dissociative anaesthesia," where the patient appears awake but is unconscious. It is the only agent that may increase ICP and cerebral blood flow.
The effect on CVS is a major factor in drug selection, especially for hemodynamically unstable patients.
Propofol: Known for causing peripheral vasodilation, which can lead to a drop in blood pressure.
Etomidate: Renowned for its cardiovascular stability, causing minimal changes in heart rate or blood pressure.
Ketamine: Stimulates the sympathetic nervous system, increasing heart rate and blood pressure.
The effect on the respiratory system is generally depressive across most agents.
Propofol & Opioids: Can cause significant respiratory depression and apnea if injected rapidly.
Ketamine: Generally preserves airway reflexes and respiratory drive, making it a safer choice in specific emergency scenarios.
Thiopental: Can cause laryngospasm or bronchospasm due to histamine release.
Choosing the agent of choice depends entirely on the patient's underlying condition and the surgical requirements:
|
Clinical Application: Agent of Choice |
|
|
Patient Condition |
Agent of Choice |
|
Routine Day-care Surgery |
Propofol (due to rapid recovery and antiemetic properties) |
|
Hemodynamically Unstable/Heart Failure |
Etomidate (due to CVS stability) |
|
Shock or Severe Asthma |
Ketamine (due to bronchodilation and BP support) |
|
Increased Intracranial Pressure |
Thiopental or Propofol |
Safety is paramount when administering anaesthesia. Below are the primary contraindications of use of intravenous anaesthetic agents that clinicians must remember:
Thiopental: Strictly contraindicated in patients with Porphyria, as it can precipitate an acute attack.
Propofol: Contraindicated in patients with known hypersensitivity to egg, soy, or the drug itself.
Etomidate: Should be avoided in patients with Adrenal Insufficiency or sepsis, as it inhibits cortisol production (adrenocortical suppression).
Ketamine: Generally contraindicated in patients with severe hypertension, ischemic heart disease, or increased intracranial pressure.
Opioids: Contraindicated in cases of severe respiratory compromise without ventilatory support.